Exelixis Inc. Common Stock vs XPO Inc. Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $59.7 (market cap $14.62B), while XPO Inc. Common Stock trades at $183.28 (market cap $21.30B). The key difference: XPO Inc. Common Stock is the larger of the two by market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, XPO Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and XPO Inc. Common Stock for 1 Days on average.
| EXEL | XPO | |
|---|---|---|
Market Cap | $14.62B | $21.30B |
Volume | 2,684,957 | 897,705 |
Sector | Health | Industrials |
52-Week High | $59.13 | $228.37 |
52-Week Low | $34.54 | $123.66 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $13.95B | $24.99B |
Trailing returns across standard periods
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →XPO provides freight transportation services in North America and Europe. Its operations include less-than-truckload freight transportation and brokerage services supported by a technology platform.
Read more on XPO →